Carisoprodol
NDC Package 67296-0271-1

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was inactivated by the FDA.

Carisoprodol is used short-term to treat muscle pain and discomfort. Marketed by Redpharm Drug Inc., this product is identified by NDC 67296-0271 and is authorized under FDA application ANDA040245.

Identification & Billing

NDC Package Code
67296-0271-1
Package Description
28 TABLET in 1 BOTTLE
Product Code
67296-0271
11-Digit Billing Format
67296027101
RxNorm Crosswalk
RxCUI: 197446 - carisoprodol 350 MG Oral Tablet

Clinical Specifications

Proprietary Name
Carisoprodol
Dosage Form
-
Usage Information
Carisoprodol is used short-term to treat muscle pain and discomfort. It is usually used along with rest, physical therapy, and other treatments. It works by helping to relax the muscles.

Regulatory & Marketing

Labeler Name
Redpharm Drug Inc.
FDA Application #
ANDA040245
Marketing Category
ANDA - A product marketed under an approved Abbreviated New Drug Application.
Start Marketing Date
09-08-1997
Listing Expiration
12-31-2017
Exclude Flag
I
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 67296-0271-1 identifies a specific commercial package of 28 tablet in 1 bottle of Carisoprodol, labeled by Redpharm Drug Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Redpharm Drug Inc. on September 08, 1997. The current certification is valid through December 31, 2017.

What are the primary indications for this medication?

Carisoprodol is used short-term to treat muscle pain and discomfort. It is usually used along with rest, physical therapy, and other treatments. It works by helping to relax the muscles.

How is this Redpharm Drug Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 67296027101. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
67296-0271-1
11-Digit CMS (5-4-2)
67296-0271-01

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.